China NMPA Drug Inspection - Shanghai Sairui Suzhou Pharmaceutical Co., Ltd. - Big hawthorn pill
China NMPA drug inspection for Shanghai Sairui Suzhou Pharmaceutical Co., Ltd. published May 10, 2018. Drug: Big hawthorn pill. This announcement from the Xinjiang Uygur Autonomous Region Food and Drug Administration, published on May 10, 2018, det
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai Sairui Suzhou Pharmaceutical Co., Ltd. published May 10, 2018. Drug: Big hawthorn pill. This announcement from the Xinjiang Uygur Autonomous Region Food and Drug Administration, published on May 10, 2018, det
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox